share_log

Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Drop in Short Interest

Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Drop in Short Interest

Q BioMed Inc.(场外交易代码:QBIO)空头股数销量大幅下降
Financial News Live ·  2022/07/28 11:11

Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% from the June 30th total of 19,200 shares. Based on an average daily volume of 844,800 shares, the short-interest ratio is currently 0.0 days.

Q BioMed Inc.(场外交易代码:QBIO-GET Rating)是新浪空头股数7月份股价大幅下降的接收方。截至7月15日,空头股数共有100股,与6月30日的19,200股相比,下降了99.5%。以日均成交量844,800股计算,短息比目前为0.0天。

Q BioMed Stock Up 50.0 %

Q BioMed股票上涨50.0%

Shares of Q BioMed stock traded up $0.06 on Thursday, hitting $0.18. The stock had a trading volume of 1,781,116 shares, compared to its average volume of 233,217. Q BioMed has a one year low of $0.04 and a one year high of $0.90. The stock has a market cap of $7.43 million, a price-to-earnings ratio of -0.58 and a beta of 1.74. The stock's 50-day simple moving average is $0.08 and its two-hundred day simple moving average is $0.23.

周四,Q BioMed的股价上涨了0.06美元,达到0.18美元。该股成交量为1,781,116股,而其平均成交量为233,217股。Q BioMed的一年低点为0.04美元,一年高位为0.90美元。该股市值为743万美元,市盈率为-0.58倍,贝塔系数为1.74。该股的50日简单移动均线切入位为0.08美元,200日简单移动均线切入位为0.23美元。

Get
到达
Q BioMed
Q BioMed
alerts:
警报:

Q BioMed Company Profile

Q BioMed公司简介

(Get Rating)

(获取评级)

Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc.是一家生物医学加速和开发公司,专注于许可、收购和向生命科学和医疗保健公司提供资源。该公司提供氯化锶SR89和美沙酮,这是一种治疗转移性骨癌疼痛的放射性药物。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
  • Is Keurig-Dr. Pepper A Value Worth Buying?
  • C3.AI Stock is a Bargain Enterprise Artificial Intelligence Game Changer
  • Did The FOMC Put A Bottom In The S&P 500?
  • Two High Yield ETF That Can Substitute For Index Funds
  • A Closer Look At Disney: Can It Earn a Place in Your Portfolio?
  • 免费获取有关Q BioMed(QBIO)的StockNews.com研究报告
  • 是Keurig-Dr。胡椒值得买吗?
  • C3AI股票是廉价企业人工智能游戏规则的改变者
  • 联邦公开市场委员会给标准普尔500指数打A底了吗?
  • 两只可替代指数基金的高收益ETF
  • 仔细看看迪士尼:它能在你的投资组合中赢得一席之地吗?

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.

接受Q BioMed Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Q BioMed和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发